We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Changes Identified in Body Cells During Type2 Diabetes Onset

Changes Identified in Body Cells During Type2 Diabetes Onset

Changes Identified in Body Cells During Type2 Diabetes Onset

Changes Identified in Body Cells During Type2 Diabetes Onset

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Changes Identified in Body Cells During Type2 Diabetes Onset"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Researchers at Dublin City University and their project partners in the EU FP7 funded DEXLIFE project have found fresh evidence to explain the processes that occur in the body’s cells leading to the onset of type2 diabetes.

To date, the molecular mechanisms, underpinning, the development of type2 diabetes is not completely understood.

This new finding is important as it demonstrates what happens at a cellular level and how diabetes and insulin resistance occur.

The research has been published in the journal Scientific Reports.

The findings show that amino acids, the building blocks of cells, play a contributory role in the onset of type2 diabetes in some younger and older patients, as the metabolism of specific amino acids is adversely affected.

The study carried out tests on the skeletal muscles and plasma from older and younger patients with type2 diabetes.

It looked at a specific set of amino acids, called branched chained amino acids (BCCA).

Results found, that type2 diabetes patients showed an impaired expression of the genes involved in BCCA metabolism when compared to obese individuals without diabetes.

These results suggest that a change in the ability of the cell to process amino acids may be an important factor in the development of type2 diabetes.

Commenting on the findings Associate Professor, DCU, Donal O’Gorman, Interim Director of the National Institute for Cellular Biotechnology and Head of the 3U Diabetes Consortium said:

“This study underlines the importance of the EU FP7 collaborative research projects.

With our DEXLIFE partners we are able to offer a new insight into the pathophysiology of type 2 diabetes.

The detailed clinical, physiological and cellular investigations performed allow us to provide an explanation for our observations in patients.”

This article has been republished from materials provided by Dublin City University. Note: material may have been edited for length and content. For further information, please contact the cited source.

María Isabel Hernández-Alvarez, Angels Díaz-Ramos, María Berdasco, Jeff Cobb, Evarist Planet, Diane Cooper, Agnieszka Pazderska, Krzystof Wanic, Declan O’Hanlon, Antonio Gomez, Laura R. de la Ballina, Manel Esteller, Manuel Palacin, Donal J. O’Gorman, John J. Nolan, Antonio Zorzano. Early-onset and classical forms of type 2 diabetes show impaired expression of genes involved in muscle branched-chain amino acids metabolism. Scientific Reports, 2017; 7 (1) DOI: 10.1038/s41598-017-14120-6.